The Insider
Meet the Fund Manager
Robert Calnon
Portfolio Manager | OC Funds Management
The Insider sessions are a great way to hear directly from leading fund managers. They share their approach to investing, favourite companies and their market view for the year ahead.**
Favourite Stocks
Learn how this in vitro fertilisation (IVF) pioneer worked its way through COVID and is now well-positioned as a ‘classic reopening trade’ with the increasing demand for IVF services.
September 23, 2021
Hear about this tech innovator that’s fulfilling huge demand across multiple industries, planning a Nasdaq dual-listing, and migrating its technology into adjacent high-performing sectors.
September 23, 2021
Learn about this energy transition company that’s capitalising on the decarbonisation of the global economy with its shipping solutions for the trillion-dollar hydrogen market.
September 23, 2021
Like these investment ideas? Join our next session to discover more like this by clicking here
Insights
Robert discusses geopolitical tensions with China, technology replacing brick-and-mortar retail, zero-immigration, inflation, interest rates, and a COVID-normal future.
September 23, 2021
Robert weighs in on a post-COVID market with OC’s preferred industry themes and companies that are expected to outperform others following the market’s recovery.
September 23, 2021
Robert Calnon joins us to talk about OC’s three favourite stocks, its investment checklist for picking winning companies, which companies will benefit from the government’s COVID roadmap, and more.
September 23, 2021
Meet the Fund Manager
Upcoming Session
Meet the Manager
Get access to some of Australia’s leading fund managers who share their 3 favourite stocks, investment approach and insights on the market.
Each session includes:
- 3 favourite stock opportunities
- Market views for the year ahead
- Investment strategy and approaches
This is a live and interactive online session, and participants are encouraged to ask questions. Joining only requires an internet connection. Spots are limited, so secure yours today.
Book into the next session
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.
Past Sessions
Matt McNamara Horizon 3 Biotech
Matt is a specialist in human healthcare technology and is passionate about investing in the commercialisation of this industry. He has spent more than 30 years in the healthcare and medical sciences sector and has more than 20 years’ experience as a venture capitalist. His business acumen and strong background in the life sciences sector make him one of the industry’s most credible investment voices.
David Keelan & Alexandra Clarke Ellerston Capital
Alexandra has worked in the finance market for 11 years and has extensive market IPO and pre-IPO experience. She provides in-depth research and analysis of stocks that range from micro to large caps covering the Industrial sector. David is a specialist investment manager with a distinctive approach to portfolio construction and investment selection.
Alex Waislitz Thorney Investment Group
Mr Waislitz is the Founder and Chairman of the Thorney Investment Group, one of Australia’s most successful private investment groups. Alex is also Chairman of Thorney Opportunities Limited (ASX: TOP) and Thorney Technologies Limited (ASX: TEK), both ASX-listed investment companies.